BridgeBio Oncology Therapeutics, Inc. Principal Accounting Officer Marc Cobo filed a Form 4 on November 17, 2026, disclosing a sale of common stock executed on November 13, 2026.

Key Highlights

  • Reporting person: Marc Cobo, Principal Accounting Officer of BridgeBio Oncology Therapeutics, Inc.
  • Transaction: 78 shares of common stock disposed of (transaction code S) on November 13, 2026
  • Sale price: $2.37 per share
  • Remaining holdings: 13,734 shares of common stock held directly following the transaction
  • 10b5-1 plan: The sale was made pursuant to a Rule 10b5-1 sales plan adopted by Cobo on July 24, 2026

Marc Cobo's November 2026 Common Stock Sale at BridgeBio Oncology

According to the filing, Marc Cobo, who serves as Principal Accounting Officer of BridgeBio Oncology Therapeutics, Inc. (NASDAQ:BBOT), sold 78 shares of the company's common stock on November 13, 2026, at a price of $2.37 per share. The transaction was reported as a direct disposal (code S) in Table I of the Form 4.

The filing indicates that the transaction was "effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on July 24, 2026." The form also notes, via a checked box, that the transaction was made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). Following the reported sale, Cobo directly held 13,734 shares of common stock, according to the filing.

No derivative securities transactions were reported in Table II of the form. The Form 4 was signed by Aaron Chan as Attorney-in-Fact on November 17, 2026, the same date it was filed with the Securities and Exchange Commission. BridgeBio Oncology Therapeutics, Inc. is located at 256 East Grand Avenue, Suite 104, South San Francisco, California 94080, as listed in the filing.

What Was Disclosed

Marc Cobo, Principal Accounting Officer of BridgeBio Oncology Therapeutics, Inc., disclosed the sale of 78 shares of common stock at $2.37 per share on November 13, 2026, under a pre-established Rule 10b5-1 plan, leaving him with 13,734 directly held shares.